nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations in vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment
|
Andrzejewski, Kelly L. |
|
2018 |
|
C |
p. 1-6 |
artikel |
2 |
Altered thalamic glucose metabolism in cerebellar projections in Parkinson’s disease
|
Pelzer, Esther |
|
2018 |
|
C |
p. 1-7 |
artikel |
3 |
Amyloid-beta 42 and Tau pathology and cognition in Parkinson's disease
|
Liepelt-Scarfone, Inga |
|
2017 |
|
C |
p. 19- 1 p. |
artikel |
4 |
An evaluative review of the evidence supporting idiopathic basal ganglia calcification for inclusion in the compassionate allowances intitiative
|
Burke, Shanna L. |
|
2017 |
|
C |
p. 1-8 8 p. |
artikel |
5 |
Anhedonia and depression – A non-motoric symptom of patients with Parkinson's disease and their relatives
|
Martin, Martha |
|
2017 |
|
C |
p. 4- 1 p. |
artikel |
6 |
Are the subthalamic nucleus, internal globus pallidus and thalamus involved in thinking?
|
Minks, Eduard |
|
2018 |
|
C |
p. 22-30 |
artikel |
7 |
Assessment of humor in Parkinson's disease and the effect of deep brain stimulation
|
Greuel, Andrea |
|
2017 |
|
C |
p. 5- 1 p. |
artikel |
8 |
Association analysis of the GABRB3 promoter variant and susceptibility to autism spectrum disorder
|
Noroozi, Rezvan |
|
2018 |
|
C |
p. 4-7 |
artikel |
9 |
A systematic review of decision-making impairments in Parkinson’s Disease: Dopaminergic medication and methodological variability
|
Kjær, Sophie Wohlert |
|
2018 |
|
C |
p. 31-40 |
artikel |
10 |
Autism, impulsivity and inhibition a review of the literature
|
Hlavatá, Pavlína |
|
2018 |
|
C |
p. 44-53 |
artikel |
11 |
Autonomic dysfunction is a major contributor to impaired health-related quality of life in advanced PD
|
Merola, Aristide |
|
2017 |
|
C |
p. 18- 1 p. |
artikel |
12 |
Biomarkers of alpha-synuclein mutations: Lect1
|
Overhoff, Melina |
|
2017 |
|
C |
p. 5- 1 p. |
artikel |
13 |
Botulinum toxin treatment of paraspinal muscles for improving abnormal posture in Parkinson’s disease
|
Matsumoto, Hideyuki |
|
2018 |
|
C |
p. 1-3 |
artikel |
14 |
Clinical characteristics and therapy of cognitive disorders in Parkinson's disease
|
Gräber, Susanne |
|
2017 |
|
C |
p. 18-19 2 p. |
artikel |
15 |
Cognition as a key factor of bladder problems in Parkinson's disease
|
Tkaczynska, Zuzanna |
|
2017 |
|
C |
p. 4- 1 p. |
artikel |
16 |
Combination of 3D and thermal images to study the subdermal distribution of botulinum toxin solution
|
Volk, Gerd Fabian |
|
2017 |
|
C |
p. 13-14 2 p. |
artikel |
17 |
Deep brain stimulation of the nucleus ventralis intermedius of the thalamus for essential tremor: The impact of DBS related improvement in postural and intention tremor on activities of daily living
|
Tischer, Martha |
|
2017 |
|
C |
p. 10- 1 p. |
artikel |
18 |
Deep Brain stimulation of the subthalamic nucleus in Parkinson's disease: Analyzing the treatment effect in patient-orientated view using definition of a “clinical substantial effect”
|
Blümel, Linda |
|
2017 |
|
C |
p. 9-10 2 p. |
artikel |
19 |
Device-based assessment through a mobile application in the Luxembourg Parkinson Cohort
|
Stallinger, Christian |
|
2017 |
|
C |
p. 2- 1 p. |
artikel |
20 |
Different aspects in the pathophysiology of dystonia
|
Zeuner, Kirsten E. |
|
2017 |
|
C |
p. 20- 1 p. |
artikel |
21 |
Duration of effect of abobotulinumtoxinA (Dysport ® ) in adult patients with lower limb spasticity post-stroke or traumatic brain injury
|
Vilain, Claire |
|
2017 |
|
C |
p. 16- 1 p. |
artikel |
22 |
Duration of effect of abobotulinumtoxinA (Dysport ® ) in adult patients with upper limb spasticity (ULS) post-stroke or traumatic brain injury
|
Vilain, Claire |
|
2017 |
|
C |
p. 15- 1 p. |
artikel |
23 |
Dysarthria and dysphagia in Parkinson syndromes
|
Simons, Janine A. |
|
2017 |
|
C |
p. 21- 1 p. |
artikel |
24 |
Echogenicity of lentiform nucleus in different types of idiopathic dystonia
|
Rohani, Mohammad |
|
2017 |
|
C |
p. 8-11 4 p. |
artikel |
25 |
Editorial Board
|
|
|
2017 |
|
C |
p. CO2- 1 p. |
artikel |
26 |
Editorial Board
|
|
|
2017 |
|
C |
p. IFC- 1 p. |
artikel |
27 |
Editorial Board
|
|
|
2017 |
|
C |
p. IFC- 1 p. |
artikel |
28 |
Editorial Board
|
|
|
2018 |
|
C |
p. IFC |
artikel |
29 |
Editorial Board
|
|
|
2018 |
|
C |
p. IFC |
artikel |
30 |
Editorial Board
|
|
|
2017 |
|
C |
p. IFC- 1 p. |
artikel |
31 |
Editorial Board
|
|
|
2018 |
|
C |
p. IFC |
artikel |
32 |
Editorial Board
|
|
|
2018 |
|
C |
p. IFC |
artikel |
33 |
Effective connectivity of the motor network in Writer's cramp
|
Tödt, Inken |
|
2017 |
|
C |
p. 12- 1 p. |
artikel |
34 |
Effects of subthalamic and nigral stimulation on gait kinematics in Parkinson's disease
|
Scholten, Marlieke |
|
2017 |
|
C |
p. 10-11 2 p. |
artikel |
35 |
Entropion senile – 25 years of experience with botulinum toxin (BoNT) therapy, including a very dramatic case
|
Stenner, Andrea |
|
2017 |
|
C |
p. 14- 1 p. |
artikel |
36 |
Evidence-based use of nuclear medicine techniques in Parkinsonian syndromes
|
Meyer, Philipp T. |
|
2017 |
|
C |
p. 21-22 2 p. |
artikel |
37 |
Examination of esophageal motor impairment in patients with Parkinson's disease with and without application of transdermal rotigotine
|
Claus, Inga |
|
2017 |
|
C |
p. 9- 1 p. |
artikel |
38 |
F-18-DOPA-PET predicts impulsive behavior under dopaminergic therapy in Parkinson patients
|
Hammes, Jochen |
|
2017 |
|
C |
p. 7- 1 p. |
artikel |
39 |
Filgrastim (G-CSF) ameliorates Parkinsonism l-dopa therapy’s drawbacks in mice
|
El-Esawy, Rasha |
|
2018 |
|
C |
p. 17-26 |
artikel |
40 |
First experience with safinamide in clinical practice
|
Mod, Andor |
|
2017 |
|
C |
p. 8-9 2 p. |
artikel |
41 |
Genetic analysis of SNCA gene polymorphisms in Parkinson’s disease in an Iranian population
|
Rahimi, Mahnoosh |
|
2017 |
|
C |
p. 4-7 4 p. |
artikel |
42 |
Health-related quality of life in Parkinson's disease analysed with the WHO-developed ICF model
|
van Uem, Janet |
|
2017 |
|
C |
p. 18- 1 p. |
artikel |
43 |
Hereditary spastic paraplegia: Clinical examination and natural history
|
Wiethoff, Sarah |
|
2017 |
|
C |
p. 21- 1 p. |
artikel |
44 |
High dose methylphenidate in the treatment of freezing of gait in advanced Parkinson’s disease
|
Reyes, Nikolai Gil D. |
|
2018 |
|
C |
p. 8-13 |
artikel |
45 |
Historical note: The first German description of writing tremor in the 19th century
|
Marsili, Luca |
|
2017 |
|
C |
p. 12-13 2 p. |
artikel |
46 |
How many steps are enough? Assessment of gait variability in realistically confined clinical settings
|
Kroneberg, Daniel |
|
2017 |
|
C |
p. 3-4 2 p. |
artikel |
47 |
How to explain patient's unsatisfaction with deep brain stimulation with great overall results in studies? A vivid example of multi-dimensional aspects in quality of life
|
Timmermann, Lars |
|
2017 |
|
C |
p. 18- 1 p. |
artikel |
48 |
“I’m doing fine but I can’t sleep” Restless Legs Syndrome after deep brain stimulation for Parkinson's disease
|
Sixel-Döring, Friederike |
|
2017 |
|
C |
p. 11- 1 p. |
artikel |
49 |
Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity
|
Jost, Wolfgang H. |
|
2017 |
|
C |
p. 14-15 2 p. |
artikel |
50 |
Impaired empathy: A non-motor symptom associated with advanced stages of Parkinson's disease
|
Schmidt, Nele |
|
2017 |
|
C |
p. 4- 1 p. |
artikel |
51 |
Impaired gait parameters are more sensitive for dual task performance than cognitive impairment in Parkinson's disease
|
Gaßner, Heiko |
|
2017 |
|
C |
p. 3- 1 p. |
artikel |
52 |
Improvement of active movement and function in adults with chronic spastic paresis following repeated treatment with abobotulinumtoxinA (Dysport ® )
|
Vilain, Claire |
|
2017 |
|
C |
p. 16- 1 p. |
artikel |
53 |
Indications for BoNT Treatment in Gastrointestinal and Genital Areas
|
Reichel, Gerhard |
|
2017 |
|
C |
p. 17- 1 p. |
artikel |
54 |
Inertial sensor-based estimation of peak accelerations during heel-strike and loading as markers of impaired gait patterns in PD patients
|
Hannink, Julius |
|
2017 |
|
C |
p. 1- 1 p. |
artikel |
55 |
Informed patients and patient-controlled medical record: Is this the future?
|
Maetzler, Walter |
|
2017 |
|
C |
p. 19-20 2 p. |
artikel |
56 |
Justinus Kerner and the “sausage poison”
|
Häfner, Steffen |
|
2017 |
|
C |
p. 14- 1 p. |
artikel |
57 |
Long-term ambulatory assessment of motor symptoms in movement disorders: a best-evidence review
|
Kramer, G. |
|
2018 |
|
C |
p. 8-21 |
artikel |
58 |
Long-term detection of motor fluctuations by wrist-worn sensors in Parkinson's disease
|
Pichler, Daniel |
|
2017 |
|
C |
p. 22- 1 p. |
artikel |
59 |
Long term essential tremor recovery after stroke thalamotomy
|
Sarchioto, Marianna |
|
2017 |
|
C |
p. 18-19 2 p. |
artikel |
60 |
Maximizing benefits of the levodopa/carbidopa intestinal gel: Systematic considerations, challenging convention and individualizing approaches
|
Vijiaratnam, Nirosen |
|
2018 |
|
C |
p. 58-60 |
artikel |
61 |
Mobile Healthcare Technologies – “Wearables” for objective measures of motor symptoms in Parkinson's disease
|
Klucken, Jochen |
|
2017 |
|
C |
p. 20- 1 p. |
artikel |
62 |
Motor fluctuations and levodopa-induced peak dose dyskinesias in parkinsonism due to spinocerebellar ataxia type 3
|
de Souza, Aaron |
|
2018 |
|
C |
p. 54-57 |
artikel |
63 |
Movement Disorders: More than just Parkinson’s disease
|
Berg, Daniela |
|
2017 |
|
C |
p. 23- 1 p. |
artikel |
64 |
Multivariate MRI atlas of Basal Ganglia for comparative studies and treatment planning in neurodegenerative movement disorders
|
Ahmadi, Seyed-Ahmad |
|
2017 |
|
C |
p. 7-8 2 p. |
artikel |
65 |
Not slow on adopting a digital lifestyle: The use of smartphones, computers and the internet in German Parkinson's disease patients
|
Marxreiter, Franz |
|
2017 |
|
C |
p. 11- 1 p. |
artikel |
66 |
Novel missense mitochondrial DNA 4079A>G variation in familial early-onset Parkinson’s disease
|
Andalib, Sasan |
|
2018 |
|
C |
p. 41-43 |
artikel |
67 |
Parkinsonism among retired Filipino boxers
|
Jamora, Roland Dominic G. |
|
2017 |
|
C |
p. 1-3 3 p. |
artikel |
68 |
Parkinson's disease and progressive dysphagia – Consider myasthenia gravis
|
Urban, Peter |
|
2017 |
|
C |
p. 3- 1 p. |
artikel |
69 |
PASS-PD: A clinically feasible measurement protocol to assess PD motor symptoms with visuoperceptive computing
|
Mansow-Model, Sebastian |
|
2017 |
|
C |
p. 1- 1 p. |
artikel |
70 |
Patients’ perspective on current treatment options for Parkinson’s Disease
|
Jost, Wolfgang H. |
|
2017 |
|
C |
p. 7-11 5 p. |
artikel |
71 |
Phenomenology and gender characteristics of hobbyism and punding in Parkinson’s disease: A self-report study
|
Callesen, Mette Buhl |
|
2017 |
|
C |
p. 1-6 6 p. |
artikel |
72 |
Preoperative stratification of gait outcome from subthalamic nucleus stimulation
|
Hanci, Idil |
|
2017 |
|
C |
p. 10- 1 p. |
artikel |
73 |
Pupil dilation under a perceptual rivalry task as an indicator of locus coeruleus activity in prodromal and manifest neurodegenerative diseases (e.g. Parkinson's disease)
|
Wilhelm, Karén |
|
2017 |
|
C |
p. 6- 1 p. |
artikel |
74 |
Putaminal iron dyshomeostasis in X-linked Dystonia-Parkinsonism
|
Hanßen, Henrike |
|
2017 |
|
C |
p. 13- 1 p. |
artikel |
75 |
Rab7 effector FYCO1 induces clearance of A53T-alpha-synuclein aggregates
|
Dinter, Elisabeth |
|
2017 |
|
C |
p. 6-7 2 p. |
artikel |
76 |
Rating of motor symptoms in Parkinson's disease – Different perspectives of the neurologist and the patient
|
Rewitzer, Charlotte |
|
2017 |
|
C |
p. 2- 1 p. |
artikel |
77 |
Recent developments in alpha-synuclein research – Clinical and preclinical data
|
Falkenburger, Björn |
|
2017 |
|
C |
p. 22- 1 p. |
artikel |
78 |
Sensor-based motor state detection in Parkinson's disease to approach personalized therapy delivery
|
Roncoroni, Lorenzo Pietro |
|
2017 |
|
C |
p. 2- 1 p. |
artikel |
79 |
Shorter pulse width reduces gait ataxia associated with VIM-DBS
|
Kroneberg, Daniel |
|
2017 |
|
C |
p. 12-13 2 p. |
artikel |
80 |
Sleep in patients with Parkinson's disease: Differences in two groups of 219 patients with and without sleep disturbances
|
Hahne, Matthias |
|
2017 |
|
C |
p. 4- 1 p. |
artikel |
81 |
SlicerDBS – Open source software tool for visualization and post-operative assessment of DBS electrode placement
|
Ahmadi, Seyed-Ahmad |
|
2017 |
|
C |
p. 8- 1 p. |
artikel |
82 |
Smoking behavior and idiopathic Parkinson's syndrome
|
Koschel, Jiri |
|
2017 |
|
C |
p. 5- 1 p. |
artikel |
83 |
State of the art neuroimaging in neurodegenerative Parkinsonian disorders: The role of structural MRI
|
Kassubek, Jan |
|
2017 |
|
C |
p. 19- 1 p. |
artikel |
84 |
Symptomatic medication of multiple system atrophy with predominant parkinsonism: Overview of 97 patients
|
Jost, Wolfgang H. |
|
2017 |
|
C |
p. 11-12 2 p. |
artikel |
85 |
Symptomatic medication of 97 patients with multiple system atrophy parkinsonian subtype: An observational study
|
Augustis, Sarunas |
|
2018 |
|
C |
p. 4-7 |
artikel |
86 |
Systematic analysis of botulinum neurotoxin type A immunogenicity in clinical studies
|
Lacroix-Desmazes, Sebastien |
|
2017 |
|
C |
p. 12-17 6 p. |
artikel |
87 |
Targeted overexpression of A53T-alpha-synuclein induces progressive neurodegeneration and electrophysiological changes of noradrenergic locus coeruleus neurons – A preclinical model of Parkinson's disease
|
Matschke, Lina |
|
2017 |
|
C |
p. 6- 1 p. |
artikel |
88 |
Tau pathology in Huntington's disease: A brief in vivo PET-imaging report
|
Giehl, Kathrin |
|
2017 |
|
C |
p. 13- 1 p. |
artikel |
89 |
The Adult Spasticity International Registry (ASPIRE) study: 1 year results
|
Jost, Wolfgang H. |
|
2017 |
|
C |
p. 15- 1 p. |
artikel |
90 |
The burden of Parkinson's disease in Germany: Incidence, prevalence and health care utilisation
|
Petersen, Gundula |
|
2017 |
|
C |
p. 9- 1 p. |
artikel |
91 |
The influence of relaxation techniques and sports on disability and therapeutic effect in patients with cervical dystonia: Results of an online survey
|
Fritz, Miriam |
|
2017 |
|
C |
p. 12- 1 p. |
artikel |
92 |
The PSC (Post Stroke Checklist) as a screening tool for post-stroke spasticity (PSS) in a German acute-care hospital: A prospective cohort study
|
Correll, Alexander |
|
2017 |
|
C |
p. 17- 1 p. |
artikel |
93 |
The SYNAPSES study (StudY to observe SafiNAmide in clinical Practice during the firSt post-commErcialization phaSe): Methodology and feasibility
|
Jost, Wolfgang H. |
|
2017 |
|
C |
p. 8- 1 p. |
artikel |
94 |
Three cases of isolated resting tremor of the lower limbs
|
Schönecker, Sonja |
|
2018 |
|
C |
p. 1-3 |
artikel |
95 |
Time to retreatment after abobotulinumtoxinA (Dysport ® ) injections in children with dynamic equinus foot deformity
|
Vilain, Claire |
|
2017 |
|
C |
p. 15-16 2 p. |
artikel |
96 |
Treatment of oromandibular dystonia using botulinum toxin injections – Case series and illustrative muscle targeting
|
Yu, Genevieve Lynn Tan |
|
2018 |
|
C |
p. 7-16 |
artikel |
97 |
Vascular factors as risk of cognitive dysfunction in PD
|
Pilotto, Andrea |
|
2017 |
|
C |
p. 19- 1 p. |
artikel |
98 |
Volumetry of substantia nigra hyperechogenity in Parkinson's disease
|
Brüggemann, Norbert |
|
2017 |
|
C |
p. 7- 1 p. |
artikel |
99 |
Which parameters generated by motor tracking devices may aid clinical decision-making?
|
Schmitz-Huebsch, Tanja |
|
2017 |
|
C |
p. 20- 1 p. |
artikel |